On ECHEMI
Home > Drugs > Xi'an Lijun Kangle Pharmaceutical Co., Ltd.
Xi'an Lijun Kangle Pharmaceutical Co., Ltd.
  • Founded in:

    1989-07-15
  • Country:

    China China
  • Address:

    In the yard of Yaocun Airport, Lintong District, Xi'an
  • Tax NO.:

    91610115221020611K
  • Registered Funds:

    120.6217 million yuan
  • Email:

Related Drugs
Compound Sodium Acetate Injection
This product is a compound preparation, each 1000ml contains: sodium acetate 12.24g, sodium chloride 11.7g, potassium chloride 0.600g, calcium chloride 0.666g.
Name Description Content CAS NO. Registered Holders
Sodium acetate

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

12.24g 127-09-3 35
Sodium chloride

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

11.7g 7647-14-5 43
Potassium chloride

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

0.600g 7447-40-7 39
Calcium chloride

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

0.666g 10043-52-4 29
Ciprofloxacin Lactate Injection
The main ingredient of this product is ciprofloxacin, whose chemical name is: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl)-3-quinolinecarboxylic acid. Molecular formula: C17H18FN3O3 Molecular weight: 331.4
Name Description Content CAS NO. Registered Holders
Ciprofloxacin

It has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial activity against most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococci, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

It has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial activity against most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococci, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

85721-33-1 19
Ciprofloxacin Lactate Injection
The main ingredient of this product is ciprofloxacin, whose chemical name is: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl)-3-quinolinecarboxylic acid. Molecular formula: C17H18FN3O3 Molecular weight: 331.4
Name Description Content CAS NO. Registered Holders
Ciprofloxacin

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often also has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial effect against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often also has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial effect against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.

85721-33-1 19
Levofloxacin Lactate Injection
Main ingredients and chemical name of this product: The main ingredient of this product is levofloxacin lactate, and its chemical name is: (S)-(-)-9-fluoro-2-,3-dihydro-3-methyl-10(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid lactate hemihydrate. [Molecular formula] C18H20FN3O4C3H6O31/2H2O [Molecular weight] 460.41
Name Description Content CAS NO. Registered Holders
LEVOFLOXACIN LACTATE

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

More

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

294662-18-3 11
Compound Sodium Acetate Injection
This product is a compound preparation, each 1000ml contains: sodium acetate 12.24g, sodium chloride 11.7g, potassium chloride 0.600g, calcium chloride 0.666g.
Name Description Content CAS NO. Registered Holders
Sodium acetate

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

12.24g 127-09-3 35
Sodium chloride

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

11.7g 7647-14-5 43
Potassium chloride

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

0.600g 7447-40-7 39
Calcium chloride

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

More

Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.

0.666g 10043-52-4 29
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.